4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-001523
Chief Financial Officer sold 2,658 shares at an average $36.30 ($96,481)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2023-01-06 | Sale | +1,836 | $36.08 | $66,241 | 34,831 | D |
| FRATES JAMES M Chief Financial Officer | 2023-01-06 | Sale | +822 | $36.79 | $30,240 | 34,009 | D |
| Open-market sales · 2,658 sh · avg $36.30 · $96,481 | |||||||
Loading xslF345X03/doc4.xml…